Join Brian Yang in this wide-ranging interview with top executives from Jiangsu Hengrui’s US subsidiary Luzsana, on topics ranging from innovation to going global, US approvals of China-made drugs and China’s regulatory harmonization efforts.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
This website doesn't track the visitors or use any cookies. Made by Alex Barredo. Send your feedback to alex@barredo.es.
